Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

NanoCross BTK, a Prospective, Non-randomized, Multicenter, Controlled Trial Evaluating the Performance of the NanoCrossTM .014 Balloon Catheter in Infrapopliteal Lesions

This study has been completed.
Information provided by (Responsible Party):
Flanders Medical Research Program Identifier:
First received: January 25, 2013
Last updated: August 10, 2016
Last verified: August 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2016
  Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)